About
Diana Goldman
Diana, the principal of DGC, has over 35 years of Quality Assurance and Quality Control experience in the biopharmaceutical and medical device industries providing QA perspective and strategy, inter-departmental coordination and practical solutions to move compounds from conception into clinical trials through launch.
DGC provides Quality Assurance, GXP Compliance and other consulting services to virtual and fully integrated biotechnology / pharmaceutical / drug device companies for all phases of product development, preclinical through commercialization.
Expertise
Our technical expertise includes support for small molecule, mAbs, proteins and peptides in parenteral, solid oral, liquid oral, topical, ophthalmic and other formulations as well as auditing and preparation for PAI, QP and partner audits. Therapeutic areas span multiple indications, such as oncology, CNS, cardiovascular, ophthalmology and multiple other therapeutic areas.
Team
DGC coordinates as necessary with Associates and other Specialists with multiple years of experience in their fields in CMC, Regulatory, Clinical, Validation, QP support and other areas of development in order to offer the fastest, scientifically justified and most compliant paths of advancing product to market.